SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biogen -- Ignore unavailable to you. Want to Upgrade?


To: Harold Engstrom who wrote (1117)8/18/1999 10:16:00 PM
From: P.M.Freedman  Respond to of 1686
 
Does anyone know the recent market prices for Avonex?.



To: Harold Engstrom who wrote (1117)8/29/1999 2:05:00 PM
From: William Partmann  Read Replies (1) | Respond to of 1686
 
Harold, any thoughts on Biogen's new hire?

Biogen Appoints Kees Been Vice President, Business & Market Development
CAMBRIDGE, Mass., Aug. 27 /PRNewswire/ -- Biogen, Inc. (Nasdaq: BGEN - news) today announced that Kees Been has been appointed Vice President, Business & Market Development, a new position. Mr. Been reports to Jim Vincent, Chairman and Chief Executive Officer.

Mr. Been joins Biogen from Monsanto Life Sciences, where he was employed since 1996 in a variety of capacities, including Vice President-Strategic Change, Vice President-Knowledge Management and, most recently, Vice President-Global Strategy. From 1988-1995, he was employed by Gemini Consulting. He began his career in 1983 as a scientist and trade and licensing manager with Biogen, based in Geneva, Switzerland.

Mr. Vincent said, ''It is a pleasure to welcome Kees Been back home to Biogen. He has a broad range of outstanding experience that will enable him to provide critical strategic leadership in our business development operation as we evaluate our internal and external opportunities for future growth.''

Mr. Been received a M.S. in Biotechnology from the University of Agriculture in The Netherlands in 1983 and a M.B.A. from INSEAD in France in 1985.